-
Virion Therapeutics Reports Broad and Sustained Anti-HBV Immunity Following a Single VRON-0200 Dose in the Majority of Chronically HBV-Infected Patients From its Phase 1b Study at CROI 2026
Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that
Lifestyle Content
Technology
-
‘War orphans’ express gratitude to Chinese foster parents
-
Vietnam Airlines Unveils Major Fleet Expansion with Up to US$ 8.1 Billion Order for 50 Boeing 737-8 Aircraft
-
Infinix NOTE 60 SERIES Brings Innovation with Interactive Design and Snapdragon Processor
-
Global Neighbors @Yiwu: Turning a Foreign Land into Home
-
Documentary series ‘My China Story’ shines spotlight on US martial artist Jake Pinnick
Entertainment
Health
-
Peace of Mind Counseling & Consulting Expands Clinical Team to Enhance Individual and Group Therapy Services Across New Jersey
-
Air Filters For Beverage Plants – How Camfil’s Clean Air Solutions Transform Beverage Production Facilities: Full Guide Now Available
-
Aron AI Launches All-In-One AI Growth Platform Built Specifically for Dental Practices
-
Jason Marker Named to the 2026 Super Lawyers List, Achieving 15 Years of Recognition
-
The Mind Behind the Money: How Brian Spira Spent 30 Years Reshaping Litigation Finance and Legal Operations
